Last reviewed · How we verify
Tadalafil 5mg
Tadalafil 5mg is a Small molecule drug developed by Aswan University. It is currently FDA-approved. Also known as: Cialis, phosphodiesterase type 5 (PDE5) inhibitor, Tadalafil, group B.
Tadalafil 5mg, marketed by Aswan University, is a well-established treatment in the erectile dysfunction market. The key composition patent is set to expire in 2028, providing a significant period of market exclusivity. The primary risk is the potential increase in competition following patent expiry.
At a glance
| Generic name | Tadalafil 5mg |
|---|---|
| Also known as | Cialis, phosphodiesterase type 5 (PDE5) inhibitor, Tadalafil, group B, Tadilecto 5 mg |
| Sponsor | Aswan University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Tadalafil 5 mg on Storage Lower Urinary Tract Symptoms After Anatomical Endoscopic Enucleation of the Prostate (PHASE1)
- Double j Stent Related Symptoms (EARLY_PHASE1)
- Randomized Controlled Trial Comparing Low Dose Tadalafil Versus Solifenacin For Management of Overactive Bladder in Women: Multicenter Egyptian National Study (PHASE4)
- Trial of Tadalafil, Tamsulosin and Combination for Access Sheath Deployment (PHASE4)
- Efficacy and Tolerability of Tadalafil Versus Darifenacin in Management of Ureteric Stent-Related LUTS (PHASE1, PHASE2)
- The Phosphodiesterase Inhibitor Tadalafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients (PHASE1, PHASE2)
- Efficacy of Tadalafil (5mg) For Treatment of Early Storage Symptoms and Erectile Dysfunction After Endoscopic Enucleation of Prostate (PHASE2, PHASE3)
- Evaluation of Tadalafil Combined With LIPUS for Treating Erectile Dysfunction (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Tadalafil 5mg CI brief — competitive landscape report
- Tadalafil 5mg updates RSS · CI watch RSS
- Aswan University portfolio CI
Frequently asked questions about Tadalafil 5mg
What is Tadalafil 5mg?
Who makes Tadalafil 5mg?
Is Tadalafil 5mg also known as anything else?
What development phase is Tadalafil 5mg in?
Related
- Manufacturer: Aswan University — full pipeline
- Also known as: Cialis, phosphodiesterase type 5 (PDE5) inhibitor, Tadalafil, group B, Tadilecto 5 mg
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing